Press Releases
Lundbeck Pharmaceuticals selects Elsevier’s Reaxys and Reaxys Medicinal Chemistry to accelerate research in neurological disorder therapies
Elsevier, the information analytics business specializing in science and health, announced that Lundbeck, the global pharmaceutical company specializing in brain diseases, has selected Elsevier’s Reaxys and Reaxys Medicinal Chemistry (RMC) to support the ambitions of its Research organization and...
Press Releases
NEX China Takes the Express for Healthy Food Together with Natural Extract Enterprises
In recent years, big health has risen as a national policy of China with the introduction of the “Healthy China 2030” Planning Outline, and China has specified the new positioning of the nutrition and health food industry. ...
Press Releases
Seize the Strategic Market of the Livestock Industry, and Build an Integrated Professional Platform for Veterinary Drugs
Animal Health & Feed Zone of CPhI China 2019 to Build a New Benchmark for the Industry Size of the global veterinary drug market continues to grow as the market continues to develop. According to the...
Press Releases
BioAsia 2019 to focus on Disruption in HealthCare, Lifesciences and Biotechnology
Over 1,500 delegates from more than 50 countries to attend Asia’s largest Biotechnology and Life-sciences forum. About 100 speakers from Government, Industry, Investors and Academia to participate in 3-day event in Hyderabad. The annual global life...
Press Releases
Linum Labs announces Molecule, a software platform and marketplace to accelerate innovation in pharma
Linum Labs, a software development studio that builds blockchain-based solutions, has announced Molecule, a market platform to accelerate innovation in the pharmaceutical and biotech industry. Molecule connects scientists, patients, and industry in order to advance drug...
Press Releases
FDA Approves Merck’s KEYTRUDA for the Adjuvant Treatment of Patients with Melanoma with Involvement of Lymph Node
Merck known as MSD outside the United States and Canada, announced that the U.S. FDA has approved KEYTRUDA, Merck’s anti-PD-1 therapy. For the adjuvant treatment of patients with melanoma with involvement of lymph node(s) following complete...
Press Releases
Top 6 Healthcare Innovations For 2019
Technology now plays a vital role in the healthcare sector. Anticipating industry innovations are critical to the prevention and treatment of specific ailments. Still, it's not enough to only learn about emerging technologies for the healthcare field. ...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read
















